FR2455896A1 - Vaccin contre l'enterotoxemie des lapins due au clostridium perfringens type e, et procede de fabrication de ce vaccin - Google Patents

Vaccin contre l'enterotoxemie des lapins due au clostridium perfringens type e, et procede de fabrication de ce vaccin

Info

Publication number
FR2455896A1
FR2455896A1 FR8010521A FR8010521A FR2455896A1 FR 2455896 A1 FR2455896 A1 FR 2455896A1 FR 8010521 A FR8010521 A FR 8010521A FR 8010521 A FR8010521 A FR 8010521A FR 2455896 A1 FR2455896 A1 FR 2455896A1
Authority
FR
France
Prior art keywords
manufacturing
enterotoxemia
clostridium perfringens
raby
vaccine against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR8010521A
Other languages
English (en)
Inventor
Roger P Orcutt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIVER BREEDING LAB Inc
Original Assignee
RIVER BREEDING LAB Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIVER BREEDING LAB Inc filed Critical RIVER BREEDING LAB Inc
Publication of FR2455896A1 publication Critical patent/FR2455896A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

VACCIN CONTRE L'ENTEROTOXEMIE DES LAPINS DUE AU CLOSTRIDIUM PERFRINGENS TYPE E, ET PROCEDE DE FABRICATION DE CE VACCIN. LE VACCIN DECRIT PAR LA PRESENTE INVENTION EST OBTENU EN RECOLTANT (OU EN CENTRIFUGEANT) UNE CULTURE EN PLEIN DEVELOPPEMENT DE LA BACTERIE ET EN SOUMETTANT LE LIQUIDE SURNAGEANT A UNE ENZYME PROTEOLYTIQUE POUR PRODUIRE UNE TOXINE DU TYPE PROTEIQUE CARACTERISEE PAR UN POIDS MOLECULAIRE DE 70000 A 80000 DALTONS, ET EN INACTIVANT LA TOXINE PAR ADDITION D'UN AGENT DE FIXATION POUR OBTENIR LA TOXOIDE.
FR8010521A 1979-05-10 1980-05-09 Vaccin contre l'enterotoxemie des lapins due au clostridium perfringens type e, et procede de fabrication de ce vaccin Pending FR2455896A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/037,734 US4264588A (en) 1979-05-10 1979-05-10 Vaccine for Clostridium perfringens type E enterotoxemia of rabbits

Publications (1)

Publication Number Publication Date
FR2455896A1 true FR2455896A1 (fr) 1980-12-05

Family

ID=21896006

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8010521A Pending FR2455896A1 (fr) 1979-05-10 1980-05-09 Vaccin contre l'enterotoxemie des lapins due au clostridium perfringens type e, et procede de fabrication de ce vaccin

Country Status (3)

Country Link
US (1) US4264588A (fr)
FR (1) FR2455896A1 (fr)
IT (1) IT1128313B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2690839A1 (fr) * 1992-05-06 1993-11-12 Rhone Merieux Ensemble de vaccination contre l'interotoxémie du lapin et vaccin conditionné pour être utilisé dans cet ensemble.

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5695956A (en) * 1990-11-26 1997-12-09 University Of Pittsburgh Of The Commonwealth System Of Higher Education Clostridium perfingens type a enterotoxin toxoid and methods of preparation and use as a vaccine and therapeutic agent
FR2768747B1 (fr) * 1997-09-19 2000-12-01 Pasteur Institut Acides nucleiques, cellules recombinantes, et procede de preparation de compositions immunogenes
US7282580B2 (en) 2001-03-29 2007-10-16 Council Of Scientific And Industrial Research Protein molecule useful for inhibition of anthrax toxin
WO2011005587A1 (fr) * 2009-06-24 2011-01-13 University Of Dubuque Compositions de vaccin et procédés d'utilisation pour protéger contre des maladies infectieuses

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2719102A (en) * 1949-10-28 1955-09-27 Corn States Serum Company Clostridium perfringens toxoid and process of making the same
GB901433A (en) * 1959-01-20 1962-07-18 Glaxo Lab Ltd Pulpy kidney disease/tetanus/lamb dysentery vaccine
GB898783A (en) * 1959-01-28 1962-06-14 Glaxo Lab Ltd Pulpy kidney disease/lamb dysentery/enterotoxaemia vaccine
GB947912A (en) * 1959-03-12 1964-01-29 Glaxo Group Ltd Braxy and/or blackleg and/or black disease vaccines
US3099601A (en) * 1959-10-02 1963-07-30 Anchor Serum Company Bacterin in aqueous polyethylene, mineral oil emulsion
GB958575A (en) * 1959-11-23 1964-05-21 Wellcome Found Vaccines containing clostridium perfringens ª‰-toxoid
GB958574A (en) * 1959-11-23 1964-05-21 Wellcome Found Clostridium perfringens ª‰-toxoid vaccines
GB958564A (en) * 1959-11-23 1964-05-21 Wellcome Found Vaccines containing clostridium perfringens ª‰-toxoid
GB895073A (en) * 1959-11-23 1962-05-02 Wellcome Found Immunising preparations containing clostridium perfringens toxins and toxoids
GB1143545A (en) * 1965-03-25 1969-02-26 Wellcome Found Injectable vaccine emulsions
FR2227861B1 (fr) * 1973-05-04 1976-07-02 Anvar
DE2355094C3 (de) * 1973-11-03 1979-05-23 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tetanus-Impfstoffs
DE2457047C3 (de) * 1974-12-03 1979-10-31 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Derivates der leichten Kette des Tetanustoxins, dessen Verwendung zur Tetanusprophylaxe

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 65, 1966, colonne 15918b, Columbus Ohio (US) *
CHEMICAL ABSTRACTS, vol. 65, 1966, colonne 9371d, Columbus Ohio (US) *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2690839A1 (fr) * 1992-05-06 1993-11-12 Rhone Merieux Ensemble de vaccination contre l'interotoxémie du lapin et vaccin conditionné pour être utilisé dans cet ensemble.
ES2104490A1 (es) * 1992-05-06 1997-10-01 Rhone Merieux Conjunto de vacunacion contra la enteroxemia del conejo y vacuna acondicionada para ser utilizada en este conjunto.

Also Published As

Publication number Publication date
IT1128313B (it) 1986-05-28
US4264588A (en) 1981-04-28
IT8048585A0 (it) 1980-05-05

Similar Documents

Publication Publication Date Title
DE3853923D1 (de) Kationisierte antikörper für das austragen durch die blut-gehirn-schranke.
DK517380A (da) Hybrid cellelinie og fremgangsmaade til fremstilling og anvendelse deraf
PT86792A (pt) Monoclonal antibodies against melanoma-associated antigens hybrid cell lines producing these antibodies and use therefor
FI902245A0 (fi) Nytt antikroppsdistributionssystem foer modifierare av biologisk respons.
CA2093928A1 (fr) Anticorps monoclonaux pour la detection et le traitement due cancer
MY108526A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
ATE233279T1 (de) Spezifisch bindende agentien
DK0754055T3 (da) Gruppe A-streptokok-polysaccharid-immunogen-præparater og metoder
OA08652A (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus HIV et procédés de production de ces anticorps et de diagnostic de la présence de ce virus.
CA2078235A1 (fr) Vaccination idiotypique contre le lymphome de lymphocyte b
DK517280A (da) Hybrid cellelinie og fremgangsmaade til fremstilling og anvendelse deraf
DK341679A (da) Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf
DE69333076D1 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis
FR2455896A1 (fr) Vaccin contre l'enterotoxemie des lapins due au clostridium perfringens type e, et procede de fabrication de ce vaccin
PT85317A (fr) Procede pour l:obtention d:imunotoxines par couplage d:un anticorps avec une proteine trichosanthine ou trickokirine
IE880976L (en) Human tumour-associated antigen
EP0339163A3 (en) Monoclonal antibodies specific for hiv and hybridomas for their production
IE36619L (en) Enzymes for reducing dental plaque
FI922220A (fi) Specifika bindemedel.
FI922666A0 (fi) Diagnostiskt foerfarande.
ES2052913T3 (es) Ensayo inmunoquimico en cuanto al factor estimulante de colonias de granulocitos-macrofagos.
FR2563630B1 (fr) Anticorps monoclonaux anticytomegalovirus et procedes pour le diagnostic in vitro des infections par les cytomegalovirus humains et d'une proteine-kinase inductible par les cytomegalovirus et susceptible d'etre reconnue par les susdits anticorps monoclonaux
DE3787239T2 (de) Komplementabhängiger zytolytischer monoklonaler Antikörper gegen Trichomonas vaginalis und seine therapeutische und diagnostische Verwendung.
ATE58397T1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
Philpot et al. Detection of antibodies to Aspergillus fumigatus in agar gel with different antigens and immunodiffusion patterns